COSELA 300 mg/20mL
trilaciclib · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Pharmacosmos Therapeutics Inc.
COSELA is a injection, powder, lyophilized, for solution containing trilaciclib at 300 mg/20mL, taken intravenous. Manufactured by Pharmacosmos Therapeutics Inc..
Key Facts
- Brand Name
- COSELA
- Generic Name
- trilaciclib
- NDC Code (Product)
73594-0101- Manufacturer
- Pharmacosmos Therapeutics Inc.
- Strength
- 300 mg/20mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA214200
- Marketing Start
- 08/25/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is COSELA used for?
COSELA contains trilaciclib. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is COSELA a controlled substance?
COSELA is not classified as a controlled substance by the DEA.
What is the generic name for COSELA?
The generic name for COSELA is trilaciclib. There are no other listed brand versions of trilaciclib.
What is the NDC code for COSELA 300 mg/20mL?
The NDC (National Drug Code) for COSELA 300 mg/20mL is 73594-0101, listed by Pharmacosmos Therapeutics Inc..
Other COSELA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)